Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Participating in the Disruption of Traditional Centralized Laboratory Testing
Point-of-care-testing offers numerous benefits, including faster results, lower costs, improved monitoring and medication adherence, and more It is set to disrupt the clinical chemistry field, promoting a shift to a more decentralized testing approach Avricore is taking part in this disruption through its POCT platform, HealthTab, found at select community pharmacies HealthTab combines point-of-care analyzers that screen for over 20 biomarkers with a consumer-facing interface that displays results Point-of-care testing (“POCT”), experts say, is set to disrupt the clinical chemistry field, with further development in this area facilitating expanded delivery of healthcare to resource-poor environments, providing better tools for monitoring…